graph EGM comparisons
doxorubicin plus cyclophosphamide followed by docetaxel plus trastuzumabtitledocetaxel plus carboplatin with trastuzumab followed by trastuzumabtitledoxorubicin plus cyclophosphamide followed by docetaxeltitleBCIRG-006 (TCH vs AC-T), 2011 NCT00021255 breast cancer - adjuvant 1075/1073BCIRG-006 (AC-TH vs TCH), 2011 NCT00021255 breast cancer - adjuvant 1074/1075BCIRG-006 (AC-TH vs AC-T), 2011 NCT00021255 breast cancer - adjuvant 1074/1073

Pathology:  breast cancer - adjuvant; 

breast cancer - adjuvant
BCIRG-006 (TCH vs AC-T), 2011BCIRG-006 (AC-TH vs TCH), 2011BCIRG-006 (AC-TH vs AC-T), 2011
doxorubicin plus cyclophosphamide followed by docetaxel plus trastuzumab2T1T1
docetaxel plus carboplatin with trastuzumab followed by trastuzumab1T1T0
doxorubicin plus cyclophosphamide followed by docetaxel0T0T0